尿激酶激活的人纤维蛋白凝块溶解的体外增强作用。 - Suppr | 超能文献

In vitro potentiation of urokinase-activated lysis of human fibrin clots.

作者信息

Singh K, Vézina C

出版信息

J Med. 1974;5(6):297-302.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

In vitro potentiation of urokinase-activated lysis of human fibrin clots.尿激酶激活的人纤维蛋白凝块溶解的体外增强作用。

J Med. 1974;5(6):297-302.

2

Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较

Thromb Haemost. 1981 Jun 30;45(3):225-9.

3

Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.组织型纤溶酶原激活剂（t-PA）与单链尿激酶型纤溶酶原激活剂（scu-PA）在体外对血凝块溶解的协同作用及其作用机制。

Thromb Haemost. 1987 Jun 3;57(3):372-3.

4

Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.去纤维蛋白原制剂安克洛酶和蝮蛇抗栓酶在血栓栓塞治疗中的应用。

Thromb Diath Haemorrh Suppl. 1973;56:239-51.

5

Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.底物组成及ε-氨基己酸对组织型纤溶酶原激活物和尿激酶诱导的纤维蛋白溶解的影响。

Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):306-24.

6

Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.体内血小板聚集抑制剂的研究。X. 与溶栓的关系。

J Med. 1982;13(5-6):365-71.

7

Selective fibrinolytic activity of recombinant non-glycosylated human pro-urokinase (single-chain urokinase-type plasminogen activator) from bacteria.细菌来源的重组非糖基化人尿激酶原（单链尿激酶型纤溶酶原激活剂）的选择性纤溶活性

Arzneimittelforschung. 1987 Aug;37(8):993-7.

8

[A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].与尿激酶原相比，一种尿激酶原与纤维蛋白特异性单克隆抗体片段的杂交分子在体外和体内都是更有效的溶栓剂。

Verh Dtsch Ges Inn Med. 1990;96:1-3.

9

Hybridization to an anti-activated platelet monoclonal antibody enhances fibrinolytic potency on urokinase.与抗活化血小板单克隆抗体杂交可增强尿激酶的纤溶效力。

Sci China B. 1993 Dec;36(12):1483-9.

10

Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型（组织型/尿激酶型）纤溶酶原激活剂的特性。

Thromb Haemost. 1993 May 3;69(5):466-72.